홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /화합물

염산미노사이클린

Mynocine hydrochloride

HCID 54706380
새 노트새 반응견적 요청하기
인쇄 미리보기
기본 정보이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
13614-98-7
표준 SMILES
CN(C)c1ccc(O)c2c1CC1CC3C(N(C)C)C(=O)C(C(N)=O)=C(O)C3(O)C(=O)C1=C2O.Cl
InChIKey
WTJXVDPDEQKTCV-UHFFFAOYSA-N
분자식
C23H28ClN3O7
평균 분자량
493.9 g/mol
단동위원소 질량
493.1615779

이름 및 식별자

우선 이름
Mynocine hydrochloride
IUPAC
4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide;hydrochloride
현지명
염산미노사이클린
영어명
Minocycline hydrochloride
분자식
C23H28ClN3O7
분자량
493.94

이름 및 동의어

Mynocine hydrochlorideC23H28ClN3O7NSC141993Minocycline hydrochloride?SCHEMBL19063414SCHEMBL29946502s4226PD055362[4S-(4a,4aa,5aa,12aa)]-4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a,tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide[4S-(4alpha,4aalpha,5aalpha,12aalpha)]-4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxonaphthacene-2-carboxamide monohydrochloride; Minocycline Hydrochloride; Minocycline hydrochloride;미노시클린수화염화물염산미노사이클린
이름 더 보기
미노시클린수화염화물(MINOCYCLINEHYDROCHLORIDE)MINOCYCLINE HCLArestinDynacinminocyclinechloride[4S-(4alpha,4aalpha,5aalpha,12aalpha)]-4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxonaphthacene-2-carboxamide monohydrochlorideminocynMINOCINtri-minoMYNOCINEMinomycin

데이터베이스 식별자

CAS
13614-98-7
PubChem CID
54706380

물성

구조 계산 물성

극성 표면적
165 Ų
수소 결합 공여자 수
6
수소 결합 수용자 수
9
회전 가능 결합 수
3
무거운 원자 수
34
형식 전하
0
복잡도
971

물리화학적 성질

녹는점
205 · 205-210° (dec)
끓는 점
813 ℃ · 813℃
인화점
110 ° · >110°(230°F)
저장 조건
2 · 2-8°C
용해도
물에 조금 녹고, 에탄올에 약간 녹습니다(96%). 알칼리 수산화물과 탄산염 용액에 용해됩니다.
물리적 상태
수정 같은
색상
노란색
수용성
물에 자유롭게 용해됨
Merck
14 · 14,6202
안정성
감광성
InChIKey
GLMUAFMGXXHGLU-VQAITOIOSA-N
SMILES
[C@@]12([H])C[C@@]3([H])C(C(=O)C4C(O)=CC=C(N(C)C)C=4C3)=C(O)[C@]1(O)C(=O)C(C(=O)N)=C(O)[C@H]2N(C)C.Cl |&1:0,3,21,31,r|
LogP
0.808 · 0.808 (est)

화학적 성질

Yellow Crystalline Powder

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

안전 데이터

wgk
3
rtecs
QI7630500
ridadr
3249
독성
human,TDLo,oral,14286ug/kg/10 (14.286mg/kg),LUNGS, THORAX, OR RESPIRATION: RESPIRATORY OBSTRUCTIONLUNGS, THORAX, OR RESPIRATION: DYSPNEASKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE",Archives of Internal Medicine. Vol. 154, Pg. 1633, 1994.
HS 번호
29413020
risk_code
36/37/38
hazard_code
Xi
safety_code
26-36
포장분류
III
위험 등급
6.1(b)
기존화학 물질
KE-03048
스토리지 클래스
11 - Combustible Solids

화학 및 산업

응용 분야 · 2건

용도Minocycline hydrochloride is a salt prepared from minocycline, taking advantage of the two basic dimethylamino groups which protonate and readily form a salt from hydrochloric acid solutions. The hydrochloride is the preferred formulation for pharmaceutical applications. Like all tetracyclines, minocycline shows broad spectrum antibacterial and antiprotozoan activity and acts by binding to the 30S and 50S ribosomal sub-units, blocking protein synthesis.

일반 설명Minocycline, 7-dimethylamino-6-demethyl-6-deoxytetracycline(Minocin, Vectrin), the most potent tetracycline currentlyused in therapy, is obtained by reductive methylationof 7-nitro-6-demethyl-6-deoxytetracycline. It was releasedfor use in the United States in 1971. Because minocycline,like doxycycline, lacks the 6-hydroxyl group, it is stablein acids and does not dehydrate or rearrange to anhydroor lactone forms. Minocycline is well absorbed orally togive high plasma and tissue levels. It has a very long serumhalf-life, resulting from slow urinary excretion and moderateprotein binding. Doxycycline and minocycline, alongwith oxytetracycline, show the least in vitro calcium bindingof the clinically available tetracyclines. The improved distributionproperties of the 6-deoxytetracyclines have been attributedto greater lipid solubility.Perhaps the most outstanding property of minocyclineis its activity toward Gram-positive bacteria, especiallystaphylococci and streptococci. In fact, minocycline hasbeen effective against staphylococcal strains that are resistantto methicillin and all other tetracyclines, includingdoxycycline. Although it is doubtful that minocyclinewill replace bactericidal agents for the treatment of lifethreateningstaphylococcal infections, it may become auseful alternative for the treatment of less serious tissueinfections. Minocycline has been recommended for thetreatment of chronic bronchitis and other upper respiratorytract infections. Despite its relatively low renal clearance,partially compensated for by high serum and tissuelevels, it has been recommended for the treatment of urinary tract infections. It has been effective in the eradicationof N. meningitidis in asymptomatic carriers.

상·하류 제품 정보

상류 원료

Minocyclinedemeclocycline hydrochloride,hemihydrate

관련 반응

0건
반응 기록 만들기

현재 필터 조건에 해당하는 반응 기록이 없습니다.

화합물 노트

불러오는 중…

이 페이지에서기본 정보이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
더보기
새 노트새 반응견적 요청하기
데메사이클린
수소
Dibenzyl azodicarboxylate